{"nctId":"NCT00769561","briefTitle":"Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders","startDateStruct":{"date":"2008-08"},"conditions":["Temporomandibular Disorders"],"count":58,"armGroups":[{"label":"BFB-CBT","type":"EXPERIMENTAL","interventionNames":["Behavioral: Biofeedback-Based Cognitive Behavioral Treatment"]},{"label":"Occlusal Splint (OS)","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Dental treatment with occlusal splint (OS)"]}],"interventions":[{"name":"Biofeedback-Based Cognitive Behavioral Treatment","otherNames":[]},{"name":"Dental treatment with occlusal splint (OS)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* clinical diagnosis of painful temporomandibular disorder according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)\n* symptoms persist at least 3 months\n* sufficient language skills\n\nExclusion Criteria:\n\n* somatic diagnosis that requires defined somatic treatment (e.g. occlusal interference)\n* presence of a psychotic disorder\n* presence of neurological disorders (e.g. dementia)\n* alcohol or substance abuse\n* presence of other pain condition of predominant severity","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pain Intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD))","description":"Characteristic pain intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)):\n\nCharacteristic pain intensity was calculated by averaging ratings of current pain, average pain, and worst pain in the past month on a numeric rating scale from 0 (no pain) to 10 (maximum pain), as recommended by RDC/TMD (range 0 - 10). Higher values indicate higher pain levels.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.40","spread":"1.94"},{"groupId":"OG001","value":"5.53","spread":"1.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.90","spread":"2.19"},{"groupId":"OG001","value":"3.89","spread":"2.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.62","spread":"2.48"},{"groupId":"OG001","value":"4.21","spread":"2.50"}]}]}]},{"type":"PRIMARY","title":"Pain Disability (Pain Disability Index)","description":"Pain related disability was assessed using the Pain Disability Index (PDI). The PDI is a brief self-rating scale which assesses the level of pain related disability in seven areas of daily life (e.g., social activity, self-care) on a 0 (no disability) -10 (maximum disability) numeric rating scale (range 0 - 70). Higher values indicate higher disability levels. Cronbach's alpha was .87 in the current sample.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.67","spread":"12.75"},{"groupId":"OG001","value":"13.88","spread":"13.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.07","spread":"12.01"},{"groupId":"OG001","value":"11.62","spread":"12.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.24","spread":"11.96"},{"groupId":"OG001","value":"11.61","spread":"11.91"}]}]}]},{"type":"SECONDARY","title":"Somatoform Symptoms (Screening for Somatoform Disorders, SOMS)","description":"Somatoform complaints during the past week were assessed using the Screening for Somatoform Symptoms (SOMS-7). 32 medically unexplained symptoms (29 for male subjects) representing DSM-IV criteria for somatization disorder were rated on a 0 ('not at all') to 4 ('very much') scale (range 0 - 128 for women and 0 - 116 for men). A sum score was calculated with higher scores indicating higher intensity and burden of somatoform complaints. In the current sample, Cronbach's alpha level was α = .88.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.97","spread":"13.63"},{"groupId":"OG001","value":"11.81","spread":"7.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.64","spread":"10.16"},{"groupId":"OG001","value":"11.30","spread":"9.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.69","spread":"9.67"},{"groupId":"OG001","value":"9.81","spread":"7.91"}]}]}]},{"type":"SECONDARY","title":"Depressive Symptoms (Centers for Epidemiologic Studies Depression Scale)","description":"Depressive symptoms were measured using the Centre for Epidemiological Studies Depression scale (CES-D). The CES-D asks for the frequency of 20 symptoms of depression during the past week on a scale ranging from 0 ('less than 1 day') to 3 ('5 to 7 days') (range 0-60). Higher scores indicate more depressive symptoms. It is suitable for use in chronic pain patients as it relies less on physical symptoms of depression than do other measures. Cronbach's alpha level in the current sample was α = .89.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.51","spread":"11.72"},{"groupId":"OG001","value":"17.38","spread":"8.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.05","spread":"8.88"},{"groupId":"OG001","value":"16.09","spread":"8.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.05","spread":"11.86"},{"groupId":"OG001","value":"16.67","spread":"10.07"}]}]}]},{"type":"SECONDARY","title":"General Anxiety Symptoms (GAD-7)","description":"General anxiety symptoms were assessed using the 7-item scale from the Patient Health Questionnaire (GAD-7). The GAD-7 asks for anxiety symptoms during the past month on a 1 ('not at all') to 3 ('more than half of the days') rating scale (range 7-21). Higher scores indicate higher levels of anxiety. Cronbach's alpha level in the current sample was α = .64.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.15","spread":"2.62"},{"groupId":"OG001","value":"14.15","spread":"2.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.07","spread":"3.44"},{"groupId":"OG001","value":"13.33","spread":"3.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.79","spread":"3.27"},{"groupId":"OG001","value":"13.04","spread":"2.92"}]}]}]},{"type":"SECONDARY","title":"Pain Coping (FESV)","description":"Cognitive and behavioral pain coping strategies were assessed with Coping Strategies Scale from the German Pain Coping Questionnaire (Fragebogen zur Erfassung der Schmerzverarbeitung, FESV). The scale asks for the use of 24 cognitive (e.g. cognitive restructuring) and behavioral (e.g. use of relaxation techniques) strategies for coping with pain on a scale ranging from 1 ('fully disagree') to 6 ('fully agree') (range 24-144). A sum score was used with higher scores indicating more adaptive coping. Cronbach's alpha level was α = .80.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.15","spread":"14.49"},{"groupId":"OG001","value":"59.35","spread":"14.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81.80","spread":"19.86"},{"groupId":"OG001","value":"64.69","spread":"20.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.11","spread":"21.04"},{"groupId":"OG001","value":"60.13","spread":"18.90"}]}]}]},{"type":"PRIMARY","title":"Jaw Use Limitations (JDL)","description":"Jaw use limitations were measured using the Jaw Disability List (JDL) from the RDC/TMD. The JDL asks the patient to rate interference with eleven oral activities, for example chewing or talking. We used an 11-point numeric rating scale (from 0 'no limitation' to 10 'maximum limitation') instead of ratings of 'yes' and 'no' (range 0 - 110). Higher values indicate higher levels of jaw use limitations. Cronbach's alpha was .86 in the current sample.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25.87","spread":"21.29"},{"groupId":"OG001","value":"27.04","spread":"16.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.52","spread":"17.94"},{"groupId":"OG001","value":"18.77","spread":"14.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.39","spread":"16.84"},{"groupId":"OG001","value":"18.11","spread":"18.02"}]}]}]},{"type":"SECONDARY","title":"TMD Related Symptoms","description":"TMD related symptoms, such as jaw pain, toothache or dizziness, were measured using a 41-item TMD symptom list. Following the SOMS-7 scale, intensity of symptoms experienced during the past week was rated from 0 ('not at all') to 4 ('very high intensity') (range 0 - 164). A sum score was built with higher scores indicating higher intensity of TMD related symptoms. The TMD symptom list has not been evaluated previously; however, large bivariate correlations with somatization (Pearson's r = .79), medium to large correlations with pain intensity (r = .48), and medium correlations with depression (r = .37) and anxiety (r = .27) provide evidence of good convergent and divergent validity. Cronbach's alpha level in the current sample was excellent (α = .93).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.69","spread":"24.12"},{"groupId":"OG001","value":"37.44","spread":"17.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.34","spread":"22.53"},{"groupId":"OG001","value":"28.15","spread":"11.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.97","spread":"23.38"},{"groupId":"OG001","value":"28.73","spread":"14.89"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Pain in teeth","Limited jaw motion","Pain in head and/or back","Jaw pain","Higher muscle tension"]}}}